Institutional Investors Show Diverging Views on Accenture Holdings

Institutional investors diverge on Accenture as some boost stakes over 60% while one sells 95%. The firm posted strong Q2 earnings and a 3.2% dividend yield.

Recent regulatory filings reveal a clear split in sentiment among major money managers regarding their stakes in global professional services giant Accenture. The fourth quarter of 2025 saw several institutions aggressively adding to their positions, while at least one notable firm executed a near-total exit.

A Divided Institutional Landscape

On the buying side, Eldred Rock Partners LLC boosted its holdings by 47.2%, bringing its total position to 51,755 shares. This investment now represents approximately 3.6% of its portfolio. An even more substantial percentage increase was recorded by Kendall Capital Management, which expanded its stake by 61.2% to 11,814 shares. Other firms reporting new purchases included Running Oak Capital, Weitz Investment, and Merit Financial.

This accumulation stands in stark contrast to the actions of Spire Wealth Management. The firm divested 95.4% of its Accenture shares, leaving it with a residual holding of just 951 shares, valued at roughly $255,000.

Financial Performance and Shareholder Returns

These portfolio adjustments occurred against a backdrop of robust financial results from the company. For the second quarter of its 2026 fiscal year, Accenture reported diluted earnings per share of $2.93, slightly exceeding analyst estimates which ranged between $2.84 and $2.85. Year-over-year revenue climbed 8% to $18.0 billion.

In light of this performance, the company declared a quarterly cash dividend of $1.63 per share. This payout translates to an annualized yield of about 3.2% for shareholders. Investors must own the stock by the ex-dividend date of April 9, 2026, to qualify for the payment, which will be distributed on May 15, 2026.

Analyst Sentiment Remains Favorable

The broader analyst community maintains a constructive outlook. Among 28 market experts covering the stock, 18 currently advocate a "Buy" rating, while 10 recommend "Hold." Their consensus price target sits at $274.88, a figure that implies significant potential upside from current trading levels. This bullish target helps contextualize the stock's present position, which trades approximately 19% below its 200-day moving average.